Skip to main content
Year archive

SYNTARA LIMITED — 2023 filings

All 72 regulatory filings released by SYNTARA LIMITED (SNT) in 2023, sourced directly from the official regulator.

72 Filings
2023 Period
2023 filings (72)
Filing Released Lang
Syntara Receives $5m R&D Tax Incentive 2 pages 496.4KB
Regulatory Filings
2023-12-04 English
Change of Company Name 2 pages 491.4KB
Regulatory Filings
2023-12-03 English
Notification regarding unquoted securities - PXS 6 pages 28.1KB
Share Issue/Capital Change
2023-11-28 English
Change of Director's Interest Notice - GP 2 pages 271.5KB
Director's Dealing
2023-11-28 English
Chair's Address to Shareholders 2 pages 170.7KB
AGM Information
2023-11-27 English
CEO Presentation to AGM 13 pages 1.4MB
Investor Presentation
2023-11-27 English
Results of Meeting 2 pages 363.9KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-27 English
Application for quotation of securities - PXS 6 pages 27.9KB
Share Issue/Capital Change
2023-11-12 English
First patient dosed in Phase 2 trial of sleep disorder 3 pages 517.3KB
Regulatory Filings
2023-11-08 English
Application for quotation of securities - PXS 6 pages 27.9KB
Share Issue/Capital Change
2023-11-05 English
Quarterly Appendix 4C Cash Flow Report 7 pages 436.8KB
Interim / Quarterly Report
2023-10-30 English
Quarterly Activities Report 11 pages 925.0KB
Interim / Quarterly Report
2023-10-30 English
Investor presentation - quarterly update 11 pages 739.6KB
Interim / Quarterly Report
2023-10-30 English
PXS Quarterly Shareholder Update and Investor Call 2 pages 186.8KB
Investor Presentation
2023-10-29 English
Notice of Annual General Meeting/Proxy Form 20 pages 902.1KB
AGM Information
2023-10-25 English
Annual Report to shareholders 70 pages 1.4MB
Annual Report
2023-10-25 English
Corporate Governance Statement 19 pages 248.7KB
Governance Information
2023-10-25 English
Appendix 4G 14 pages 270.4KB
Regulatory Filings
2023-10-25 English
Pharmaxis Completes Sale of Mannitol Business 2 pages 193.8KB
Capital/Financing Update
2023-10-18 English
Investor Presentation 33 pages 2.2MB
Investor Presentation
2023-10-16 English
Notification regarding unquoted securities - PXS 7 pages 30.1KB
Share Issue/Capital Change
2023-10-11 English
Notification of cessation of securities - PXS 4 pages 23.8KB
Share Issue/Capital Change
2023-10-05 English
PXS Company Restructure Sale of Mannitol Business 5 pages 515.0KB
Board/Management Information
2023-10-02 English
Investor Presentation 17 pages 1.8MB
Investor Presentation
2023-10-02 English
Final Directors Interest Notice 2 pages 122.3KB
Director's Dealing
2023-10-02 English
Final Directors Interest Notice 2 pages 121.2KB
Director's Dealing
2023-10-02 English
Trading Halt 2 pages 574.2KB
Regulatory Filings
2023-10-01 English
Date of Virtual AGM Date for Receipt of Director Nominations 1
AGM Information
2023-09-12 English
Application for quotation of securities - PXS 6 pages 27.9KB
Capital/Financing Update
2023-08-31 English
Nature Cancer Publishes Results of PXS Garvin Collaboration 3 pages 266.3KB
Regulatory Filings
2023-08-28 English
Preliminary Final Report 67 pages 2.5MB
Annual Report
2023-08-27 English
Change in substantial holding 7 pages 946.2KB
Regulatory Filings
2023-08-13 English
PXS to Receive Prepayment of 2023 Research Tax Incentive 2 pages 193.5KB
Capital/Financing Update
2023-08-07 English
Notification of cessation of securities - PXS 4 pages 23.8KB
Regulatory Filings
2023-08-07 English
Application for quotation of securities - PXS 6 pages 27.9KB
Share Issue/Capital Change
2023-08-07 English
Quarterly Appendix 4C Cash Flow Report 6 pages 361.2KB
Interim / Quarterly Report
2023-07-30 English
Quarterly Activities Report 11 pages 722.0KB
Interim / Quarterly Report
2023-07-30 English
Pharmaxis Quarterly Shareholder Update and Investor Briefing 2 pages 209.7KB
Investor Presentation
2023-07-27 English
Ceasing to be a substantial holder 2 pages 89.3KB
Major Shareholding Notification
2023-07-25 English
Investor Presentation 30 pages 3.1MB
Investor Presentation
2023-07-19 English
PXS to Present at MST Access Biotech Hidden Gems Forum 2 pages 192.3KB
Regulatory Filings
2023-07-17 English
Final Set of Interim Data from PXS-5505 in Myelofibrosis 3 pages 253.6KB
Capital/Financing Update
2023-07-11 English
Investor Presentation MF 101 Interim Data 10 pages 731.3KB
Investor Presentation
2023-07-11 English
Change in substantial holding 7 pages 858.5KB
Regulatory Filings
2023-07-04 English
Notification of cessation of securities - PXS 4 pages 23.8KB
Share Issue/Capital Change
2023-07-04 English
Application for quotation of securities - PXS 6 pages 27.9KB
Capital/Financing Update
2023-07-04 English
Investor presentation 11 pages 1.5MB
Investor Presentation
2023-05-23 English
PXS Announces Encouraging Results from Phase 1c Scar Study 4 pages 243.2KB
Regulatory Filings
2023-05-22 English
Trading Halt 2 pages 383.0KB
Regulatory Filings
2023-05-21 English
Quarterly Activities/Appendix 4C Cash Flow Report 5 pages 333.5KB
Interim / Quarterly Report
2023-04-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 635.8KB
Interim / Quarterly Report
2023-04-27 English
Investor Presentation - Quarterly Briefing 6 pages 1.0MB
Investor Presentation
2023-04-27 English
PXS Quarterly Update and Investor Briefing 2 pages 205.0KB
Investor Presentation
2023-04-20 English
After FDA Review PXS Accelerates Plans for Combination Study 3 pages 224.5KB
Regulatory Filings
2023-04-11 English
Ceasing to be a substantial holder 7 pages 83.5KB
Major Shareholding Notification
2023-03-30 English
Pharmaxis Drug Study Published in Nature Communications 3 pages 222.5KB
Regulatory Filings
2023-03-22 English
Becoming a substantial holder 6 pages 103.4KB
Major Shareholding Notification
2023-03-21 English
Change in substantial holding 3 pages 90.6KB
Major Shareholding Notification
2023-03-20 English
Application for quotation of securities - PXS 6 pages 27.8KB
Share Issue/Capital Change
2023-03-19 English
Application for quotation of securities - PXS 6 pages 28.2KB
Share Issue/Capital Change
2023-03-15 English
PXS Securities Trading Policy - Updated 10 Feb 2023 9 pages 232.7KB
Governance Information
2023-02-12 English
Change in substantial holding 3 pages 637.6KB
Major Shareholding Notification
2023-02-12 English
Half Yearly Report and Accounts 24 pages 738.8KB
Interim / Quarterly Report
2023-02-09 English
Investor Presentation 28 pages 2.7MB
Investor Presentation
2023-02-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 5 pages 226.2KB
Interim / Quarterly Report
2023-01-30 English
Quarterly Activities Report 12 pages 523.6KB
Interim / Quarterly Report
2023-01-30 English
Investor Presentation 9 pages 586.1KB
Investor Presentation
2023-01-30 English
Application for quotation of securities - PXS 6 pages 27.8KB
Capital/Financing Update
2023-01-22 English
Quarterly Shareholder Update and Investor Briefing 2 pages 127.9KB
Regulatory Filings
2023-01-22 English
Director Appointment/Resignation 2 pages 111.4KB
Board/Management Information
2023-01-15 English
Initial Director's Interest Notice 2 pages 141.0KB
Director's Dealing
2023-01-15 English
Pharmaxis Receives $5m R&D Tax Incentive 2 pages 90.0KB
Capital/Financing Update
2023-01-08 English